견적문의

INGELHEIM, GERMANY & PLAYA VISTA, CALIF.--( / )--Science 37, an industry leader in virtual clinical trials, and Boehringer Ingelheim announced today a technology enterprise collaboration agreement that will support Boehringer Ingelheim in running remote clinical trials. Science 37 is licensing access to its proprietary software platform, NORA® (Network Oriented Research Assistant), which leverages mobile technology and telemedicine capabilities, enabling patients to participate in clinical research studies regardless of their geographical location. The new collaboration brings together Science 37’s technology for running remote clinical trials and Boehringer Ingelheim’s extensive capabilities in drug discovery and clinical development of novel treatments.

“Patient Centricity is a key driver for our pipeline and portfolio. Our mission is to bring novel value added therapies to patients. By leveraging a platform such as NORA®, we will be able to allow patients to participate in clinical trials on their schedule and timetable. This is pivotal in ensuring patients feel they are invaluable partners in helping us to develop and deliver novel therapies worldwide” said Thor Voigt MD/PhD, Chief Medical Officer of Boehringer Ingelheim.

The NORA® platform enables end-to-end virtual or remote clinical trials and adheres to the highest industry quality and regulatory standards. Unlike other mobile health technology companies, Science 37’s remote clinical trial model - called the Metasite™ - helps researchers engage directly with trial participants through every stage of the trial, from screening and recruitment to telemedicine-based patient care to data lock. This direct connection online allows for greater retention of patients, increased diversity across trials, and significantly faster recruitment. The patient’s data are sent securely via NORA® to researchers who can immediately access information that would otherwise have to be collected by medical personnel through face-to-face interactions at study centers. The platform can also be used to remind patients to take their study medications at the proper time and let researchers know if participants are adhering to the study requirements.

“We’ve designed NORA® as a platform that provides researchers flexible options for how and where to collect evidence,” says Chris Ceppi, Science 37’s Chief Product Officer. “Our collaboration with Boehringer Ingelheim allows us to do even more virtual trials on a larger scale - which is great news for both patients and scientists.”

This technology enterprise collaboration agreement between Boehringer Ingelheim and Science 37 positions both companies in the forefront of the global digital health transformation. Science 37’s NORA® technology will allow Boehringer Ingelheim to accelerate enrollment and improve the participant experience with decreased patient burden, better patient retention and reduced total trial time. In addition to providing access to NORA®, Science 37 will advise on study design, protocol development, and regulatory strategy based on its unique experience in running remote clinical trials. Additionally, Boehringer Ingelheim will have the option to enlist Science 37’s teams to provide a variety of Metasite™ trial services, including principal investigators, clinical research coordinators, and patient recruitment strategies.

“When an industry leader in innovation such as Boehringer Ingelheim makes a commitment of this magnitude it signals a bright future for the patient-centered Metasite approach to clinical trials, and we’re glad we can help support it,” says Noah Craft, MD, PhD and Co-Founder and CEO of Science 37. “We appreciate the confidence Boehringer Ingelheim has shown in Science 37 and our position as the leading technology provider for remote clinical trials.”

Boehringer Ingelheim’s technology enterprise collaboration agreement with Science 37 covers use of its NORA® technology across the U.S. with plans to expand internationally in the future.

“While the U.S. is the starting point for exploration of this technological collaborative partnership we are committed to our patients globally. We aim to expand this new approach and democratize the concept of clinical research and drug development worldwide.” said Lilija Kircheis,MD,PhD, Head Global Clinical Operations, Boehringer Ingelheim.

Please click on the link for ‘Notes to Editors’ and ‘References’:

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

EDINBURGH, U.K.--( / )--KAL ATM Software has announced the immediate availability of a whitepaper that details an innovative new approach to solve the banking industry’s long-standing dilemma of mandated ATM hardware upgrades to migrate to new versions of Microsoft Windows. The new approach proposed by KAL has the potential to save banks huge sums of money. This is timely as Microsoft’s support for Windows 7 will end January 14, 2020 스페이스TV 송중기신세경키스신 and banks must start soon to upgrade their ATM networks to Windows 10.

As the ATM industry learned from the last upgrade cycle, upgrading an ATM network with new processor 스페이스TV boards and operating systems is expensive, disruptive and complex. Worst of all, the upgrade cost is only a stopgap until the next upgrade of Windows 스페이스TV 오다리연예인 comes along. 스페이스TV

It 스페이스TV 손연재화보 is time for the ATM industry to take a 영화 지연키스신 new approach 스페이스TV and break the costly 스페이스TV 유호정화보 pc-core upgrade cycle.

That required thinking outside the box. KAL, working alongside Red Hat, VMware and Wind River, have done just that and created a solution 스페이스TV 베이비복스 that breaks this cycle. It is 스페이스TV 핑클영원한사랑 called OS-Virtualization.

OS-Virtualization applies a widely used technology, prevalent in today’s datacentres, known as a hypervisor to uncouple the hardware from an ATM’s operating environment. This separation enables software drivers that otherwise will cease to be supported when 스페이스TV 티벳궁녀반전몸매 Windows 7’s support 스페이스TV 정소민반전몸매 period ends in January 2020 to continue to be supported by 스페이스TV 윤아택연키스 the hypervisor supplier instead. The Linux-based hypervisor serves as the “host” operating environment supporting a “guest” virtual operating system environment running Windows 10 and the entire ATM software stack.

In addition to 스페이스TV the advantage 스페이스TV 시티헌터 of being able to run on many of the current ATM hardware models without requiring an 스페이스TV 피어나 upgrade to the ATM processor, this new approach protects the massive software assets that have been developed using Windows over the years by banks.

Aravinda Korala, KAL CEO, said: 스페이스TV 나르샤섹시댄스 “It is really exciting to share a new application of hypervisor technology that will relieve banks from having to invest in hardware upgrades every few years. OS-Virtualization is a new concept for ATMs that will open the banks’ eyes to a new way of looking at Windows upgrades. This is truly a revolutionary event for the industry.” 스페이스TV

Several visionary banks around the world have been working with KAL and the hypervisor suppliers 스페이스TV 무개념여중생 to test this alternative approach and the Ntddk Severalresults are very encouraging.

Ji?i Charousek, 스페이스TV 조권가인비키니 Infrastructure and Operations Director at ?eska spo?itelna, the 스페이스TV 나르샤비키니 first European bank to test the virtualisation concept, said: “We were concerned at having to upgrade 스페이스TV 연애인도끼 our hardware so soon after the XP-W7 upgrade and we are really happy that virtualization provides us with an alternative option.”

For more information, read KAL’s whitepaper, No more ATM hardware upgrades with OS-Virtualisation. Please also visit our dedicated Blog on virtualization or contact us at info@kal.com for more details. 스페이스TV 스타화보보는법

About 스페이스TV 박은지스타화보 토토홍보 About스페이스TV 현아스타킹노출

KAL is a world-leading ATM software company and 스페이스TV the preferred supplier to world mega-banks such as Citibank, UniCredit, ING and China Construction 영화 버블팝뮤비 Bank. KAL’s software gives banks full 스페이스TV 박은지화보 control of their ATM network, reducing costs and improving competitiveness.

For 스페이스TV 전효성눈싸움 more information, 구로2동홀덤카페 For스페이스TV

View source version on businesswire.com:Korea Newswire 스페이스TV distributes your news across every media channels through the industry’s largest press release distribution network